Peptide Catalog

Retatrutide (LY3437943) is an experimental peptide developed by Eli Lilly that acts simultaneously on three metabolic receptors: GLP-1, GIP and glucagon. This triple action makes it the most potent agent of its class in obesity clinical trials, with average weight losses exceeding 24% of body weight over 48 weeks. Its mechanism combines appetite suppression (GLP-1), improved insulin sensitivity (GIP) and increased basal energy expenditure (glucagon), producing a synergistic effect on metabolism.

High-concentration version of Retatrutide for advanced users or prolonged protocols. Same triple-agonist mechanism (GLP-1, GIP and glucagon) but with a vial that yields enough for longer cycles or higher doses. Indicated when seeking to optimize cost per dose or when the protocol requires progressive escalation up to maximum doses (8–12 mg weekly).

Tirzepatide (Mounjaro/Zepbound) is a dual GLP-1/GIP agonist approved by the FDA for type 2 diabetes and obesity. It mimics two gut hormones that regulate appetite, glucose and gastric emptying. In the SURMOUNT trials it produced average weight losses of 20.9% at 72 weeks, making it the current clinical gold standard for the pharmacological treatment of obesity.

Human Chorionic Gonadotropin (HCG) is a glycoprotein hormone that mimics the action of luteinizing hormone (LH), directly stimulating testicular Leydig cells to produce endogenous testosterone. It is used in male fertility protocols, recovery of the HPG axis after steroid cycles (PCT), and maintenance of testicular volume in hormone replacement therapy (TRT). In women it is used for ovulation induction.

GHK-Cu is a tripeptide (glycyl-L-histidyl-L-lysine) bound to a copper atom that occurs naturally in human plasma and declines with age. It acts as a tissue-repair signal, modulating the expression of more than 4000 genes related to wound healing, collagen remodeling, antioxidation and regeneration. The blue-purple color of the powder is characteristic and confirms the integrity of the copper complex.

NAD+ (Nicotinamide Adenine Dinucleotide) is an essential coenzyme present in every cell that takes part in more than 500 metabolic reactions, primarily in energy production (ATP) and DNA repair. Its levels decline drastically with age, and exogenous replenishment is associated with improvements in energy, mitochondrial function, cognitive function and longevity markers. It is one of the pillars of modern anti-aging biohacking.

BPC-157 (Body Protection Compound) is a 15-amino-acid peptide derived from a protective protein found in human gastric juice. It works as a systemic repair signal: it accelerates the healing of soft tissues, protects the digestive tract, and modulates inflammation without suppressing the immune system. Its core mechanism is the promotion of angiogenesis (the formation of new blood vessels) and the regulation of growth factors such as VEGF and nitric oxide.

A synergistic blend that combines TB-500 (Thymosin Beta-4) and BPC-157 in a single vial (5 mg + 5 mg). TB-500 promotes cell migration and systemic angiogenesis, while BPC-157 accelerates local healing and protects tissues. Together they cover both repair mechanisms: systemic and focal. It is the reference protocol for soft-tissue injury recovery, especially chronic tendinopathies and complex sports injuries.

High-concentration presentation of the TB-500 + BPC-157 blend (10 mg + 10 mg per vial). Intended for users who require extended cycles, complex injuries or high doses without having to manage multiple vials. Same synergistic profile as the 5+5 version but with double the yield per vial, which makes it more practical for professional recovery protocols or high-volume athletes.

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a modified version of natural IGF-1 with an extended half-life of ~20–30 hours (vs. 15 minutes for native IGF-1). It acts directly on IGF-1 receptors to stimulate protein synthesis, muscle hyperplasia (the creation of new muscle cells), and tissue recovery. It is one of the most potent compounds for lean-mass gain and repair in the performance world.

GHRP-6 (Growth Hormone Releasing Peptide-6) is a hexamer peptide that stimulates the pulsatile release of growth hormone (GH) from the pituitary gland by activating the ghrelin receptor. Unlike other GHRPs, GHRP-6 produces a pronounced secondary effect: a significant increase in appetite, which makes it a useful option for athletes in a muscle-gain (bulking) phase or for individuals who struggle to raise their caloric intake.

Ipamorelin is a GH secretagogue pentapeptide considered the most selective and 'cleanest' of its class. Unlike GHRP-6 or GHRP-2, it does not cause a notable rise in cortisol, prolactin or appetite, making it the preferred option for anti-aging, fat-loss and recovery protocols without hormonal side effects. It generates a physiological GH pulse similar to the natural one, ideal for prolonged use.

Epithalon (Epitalon) is a synthetic tetrapeptide developed in Russia from studies with pineal-gland extracts. Its main mechanism is the activation of the enzyme telomerase, which lengthens the telomeres (the protective ends of the chromosomes) and delays cellular senescence. Long-term studies in elderly subjects have shown reduced mortality and improvements in aging biomarkers.

CJC-1295 No DAC (without Drug Affinity Complex), also called Modified GRF 1-29, is a synthetic analog of growth hormone-releasing hormone (GHRH) with a short half-life (~30 minutes). This generates a physiological GH pulse similar to the natural one, without sustained elevations that could desensitize the pituitary. It is almost always combined with a GHRP (Ipamorelin or GHRP-6) for a synergistic effect 5–10 times greater than either one alone.

Tesamorelin is a synthetic GHRH analog approved by the FDA for the treatment of HIV-associated lipodystrophy, known for its efficacy in reducing abdominal visceral fat. It stimulates the pituitary to release GH in a pulsatile manner, with potency superior to CJC-1295. It is the only secretagogue with robust clinical evidence for visceral fat reduction and improvement of hepatic markers in non-alcoholic fatty liver disease.

MOTS-c (Mitochondrial Open Reading frame of the Twelve S rRNA-c) is a 16-amino-acid peptide encoded by mitochondrial DNA, not nuclear DNA. It is considered a 'mitochondrial hormone' that regulates energy metabolism, insulin sensitivity and physical endurance. Its levels decline with age and are associated with obesity, type 2 diabetes and loss of muscle function.

Selank is a synthetic heptapeptide derived from human tuftsin, developed in Russia. It acts as an anxiolytic without the sedative or addictive effects of benzodiazepines, modulating serotonin, dopamine and the GABA system. It is administered primarily by the intranasal route and has a rapid onset of action (15–30 minutes). Used clinically in Russia for generalized anxiety disorders.

Semax is a synthetic heptapeptide derived from the ACTH (4-10) hormone, developed in Russia and approved there for strokes and cognitive disorders. It works by increasing BDNF (neurotrophic factor) and NGF, modulating dopamine and serotonin, and improving neuroplasticity. It is one of the most potent peptide nootropics available, with a rapid effect via the intranasal route.

Glow Blend combines in a single vial the three most potent peptides for aesthetics and regeneration: GHK-Cu 50 mg (cutaneous signaling and anti-aging), BPC-157 10 mg (tissue repair) and TB-500 10 mg (systemic regeneration), for a total of 70 mg of active peptides per vial. The characteristic blue-purple color confirms the presence of the copper complex. This combination targets every front simultaneously: collagen, wound healing, inflammation, hair growth and skin firmness.

KPV (Lysine-Proline-Valine) is the active C-terminal fragment of the hormone α-MSH, with potent anti-inflammatory action but without the pigmentary or sexual effects of its parent molecule. It modulates the immune response and reduces inflammation at the cellular level, with particular affinity for the gastrointestinal tract and the skin. It is an emerging alternative for inflammatory bowel disease (IBD), colitis, atopic dermatitis and acne.

Kisspeptin-10 is a decapeptide discovered in 1996 that acts as the 'master regulator' of the hypothalamic-pituitary-gonadal (HPG) axis. It stimulates the release of GnRH, which in turn activates LH and FSH, triggering endogenous testosterone production in men and estrogen production in women. It is an emerging tool for infertility, functional hypogonadism, libido, and post-steroid-cycle recovery.

PT-141 (Bremelanotide) is a synthetic α-MSH analog that acts on the MC3R and MC4R melanocortin receptors in the central nervous system, activating sexual desire directly from the brain (not through the vascular route like sildenafil). FDA-approved under the name Vyleesi for female hypoactive sexual desire disorder, it is also used off-label in men with erectile dysfunction of non-vascular origin.

Melanotan II is a synthetic analog of the α-MSH hormone that activates the melanocortin receptors, stimulating melanin production and generating a protective tan against UV radiation. It also has desirable secondary effects such as increased libido, mild appetite suppression, and improvement of the metabolic profile. Very popular among fair-skinned people who seek to tan with less sun exposure.